Search

Your search keyword '"Bednarski, Jeffrey J."' showing total 290 results

Search Constraints

Start Over You searched for: Author "Bednarski, Jeffrey J." Remove constraint Author: "Bednarski, Jeffrey J."
290 results on '"Bednarski, Jeffrey J."'

Search Results

1. Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

2. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study

5. A Case of Severe Combined Immunodeficiency Missed by Newborn Screening

6. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study

7. Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function

8. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

9. Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.

10. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

11. Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

12. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions

14. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC

15. Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant

17. Outcomes Following Matched Sibling Donor Transplant for Severe Combined Immunodeficiency: A Report from the Pidtc

18. Donor-Derived Memory-like NK Cells for the Treatment of Children and Young Adults with Relapsed AML Following Allo-HCT

22. A Novel Secreted Protein, MYR1, Is Central to Toxoplasma’s Manipulation of Host Cells

24. MYSM1 attenuates DNA damage signals triggered by physiologic and genotoxic DNA breaks

25. The SMC5/6 complex is required for maintenance of genome integrity upon APOBEC3A-mediated replication stress

26. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis

27. Correction to: Infections in Infants with SCID: Isolation, Infection Screening and Prophylaxis in PIDTC Centers

29. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study

30. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

33. Brief IL-12, IL-15, IL-18 activation drives the acquisition of two distinct memory-like NK cell states

35. Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy

37. Allogenic Hematopoietic Cell Transplantations Are Effective in Patients with p47phox Chronic Granulomatous Disease: A Primary Immune Deficiency Treatment Consortium Study

43. 116 - Event Free Survival in Severe Combined Immune Deficiency (SCID) Infants after Conditioned Umbilical Cord Blood Transplantation (UCBT) Benefits from Omitting Serotherapy

48. Cytokine-Induced Memory-like NK Cells Have a Distinct Single Cell Transcriptional Profile and Persist for Months in Adult and Pediatric Leukemia Patients after Adoptive Transfer

50. Nuclease‐independent functions of RAG1 direct distinct DNA damage responses in B cells.

Catalog

Books, media, physical & digital resources